New drug combo tested in fight against hepatitis b
NCT ID NCT07183306
Summary
This study is testing the safety and effects of two new injections, HT-101 and HT-102, in people with chronic hepatitis B. About 86 participants will receive the injections every four weeks for up to 48 weeks, while continuing their standard antiviral pills. The main goal is to see if the treatments are safe and how they behave in the body, while also checking if they can lower hepatitis B virus levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Ditan Hospital Capital Medical University
Beijing, Beijing Municipality, 100015, China
-
Guangzhou Eighth People's Hospital, Guangzhou Medical University
Guangzhou, Guangdong, 510440, China
-
Nanfang Hospital
Guangzhou, Guangdong, 510515, China
-
Qingyuan People's Hospital
Qingyuan, Guangdong, 511518, China
-
Shanghai Public Health Clinical Center
Shanghai, Shanghai Municipality, 200083, China
-
Sichuan Provincial People's Hospital
Chengdu, Sichuan, 610072, China
-
Xiamen Hospital of Traditional Chinese Medicine
Xiamen, Fujian, 361001, China
Conditions
Explore the condition pages connected to this study.